SAS | The Power to Know
cq5dam.thumbnail.319.319
White Paper

Learning to Share - Sharing to Learn: Honoring Patients Through Collaboration and Transparency

Exploring the emerging trend of data-sharing initiatives in the life sciences industry

About this paper

Pressured by new regulations, public image issues, negative publicity and a desire to promote better use of health data, pharmaceutical companies and other clinical trial sponsors are starting initiatives to expose and share their clinical trial information. Recent announcements to share previously confidential data include those by GlaxoSmithKline and the CEO Roundtable on Cancer. In addition to positive media attention and altruistic reasons, pharmaceutical companies also see this as an opportunity to improve the research process and increase the opportunities to identify scientific breakthroughs helping both their companies as well as the larger healthcare environment. Providing access to clinical trial data with the ability to aggregate information for meta-analyses greatly increases the likelihood for identifying new medical breakthroughs as well as decreasing the time to market for

Über SAS

SAS ist weltweit Marktführer im Bereich Analytics und mit 3,16 Milliarden US-Dollar Umsatz einer der größten Softwarehersteller. Kunden an mehr als 80.000 Standorten setzen innovative Analytics-, Business-Intelligence- und Datenmanagement-Software und -Services von SAS ein, um schneller bessere Geschäftsentscheidungen zu treffen. Seit 1976 verschafft SAS Kunden rund um den Globus THE POWER TO KNOW.

Firmensitz der US-amerikanischen Muttergesellschaft ist Cary, North Carolina. SAS Deutschland hat seine Zentrale in Heidelberg und weitere Niederlassungen in Berlin, Frankfurt, Hamburg, Köln und München. Weitere Informationen über SAS.

Sie haben bereits ein SAS Profil? Um das Formular automatisch auszufüllen, hier anmelden: Einloggen

*
*
*
*
 
*
*
 
 

Back to Top